Dominant negative STAT-3 mutations in hyper-IgE syndrome

被引：0

作者：

Dereure, O. ^{[1
]}

机构：

[1] Hop St Eloi, Serv Dermatol, F-34295 Montpellier 5, France

来源：

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2008年 / 135卷 / 05期

关键词：

D O I：

10.1016/j.annder.2008.02.010

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：432 / 432

页数：1

共 50 条

[31] STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions
Christo Tsilifis
Alexandra F. Freeman
Andrew R. Gennery
Journal of Clinical Immunology, 2021, 41 : 864 - 880
[32] Genetic Test for Mutations in STAT3 Gene Associated With Hyper-IgE Syndrome (Job's Syndrome)
Smith, M. S.
Walters, P.
Altrich, M.
Ling, M.
CLINICAL IMMUNOLOGY, 2010, 135 (02) : 334 - 334
[33] Hyper-IgE syndrome with a novel mutation of the STAT3 gene
Minakawa, S.
Tanaka, H.
Kaneko, T.
Matsuzaki, Y.
Kono, M.
Akiyama, M.
Minegishi, Y.
Sawamura, D.
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2016, 41 (06) : 687 - 689
[34] Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry
Gernez, Yael
Freeman, Alexandra F.
Holland, Steven M.
Garabedian, Elizabeth
Patel, Niraj C.
Puck, Jennifer M.
Sullivan, Kathleen E.
Akhter, Javeed
Secord, Elizabeth
Chen, Karin
Buckley, Rebecca
Haddad, Elie
Ochs, Hans D.
Fuleihan, Ramsay
Routes, John
Muskat, Mica
Lugar, Patricia
Mancini, Julien
Cunningham-Rundles, Charlotte
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (03): : 996 - 1001
[35] Haematopoietic Stem Cell Transplantation May Resolve the Immune Deficit Associated with STAT-3 Deficient Hyper-IGE Syndrome
Harrison, S.
Slatter, M.
Nademi, Z.
Jolles, S.
Al-Herz, W.
Flood, T.
Cant, A.
Doffinger, R.
Glocker, C.
Grimbacher, B.
Abinun, M.
Gennery, A.
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S209 - S210
[36] Location of STAT3 hyper-IgE syndrome mutations does not invariably correlate with STAT3 phosphorylation potential
Chaimowitz, Natalia
Vargas-Hernandez, Alexander
Vogel, Tiphanie
Forbes, Lisa
JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (03) : 381 - 381
[37] Mutations in the signal transducer and activator of transcription 3 (STAT3) and diagnostic guidelines for the Hyper-IgE Syndrome
Woellner, C.
Gertz, M. E.
Schaffer, A. A.
Lagos, M.
Perro, M.
Glocker, E.-O.
Pietrogrande, M. C.
Cossu, F.
Franco, J. L.
Matamoros, N.
Pietrucha, B.
Heropolitanska-Pliszka, E.
Yeganch, M.
Moin, M.
Espanol, T.
Ehl, S.
Gennery, A. R.
Abinun, M.
Breborowicz, A.
Niehues, T.
Kilic, S. S.
Junker, A.
Turvey, S. E.
Plebani, A.
Sanchez, B.
Garty, B-Z
Pignata, C.
Cancrini, C.
Litzman, J.
Sanal, O.
Batimann, U.
Bacchetta, R.
Hsu, A. P.
Davis, J. N.
Hammarstrom, L.
Davies, G. E.
Eren, E.
Arkwright, P. D.
Moilanen, J. S.
Viemann, D.
Khan, S.
Marodi, L.
Cant, A. J.
Freeman, A. F.
Puck, J. M.
Holland, S. M.
Grimbacher, B.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 160 : 4 - 4
[38] Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES)
Spielberger, Benedikt D.
Woellner, Cristina
Dueckers, Gregor
Sawalle-Belohradsky, Julie
Hagl, Beate
Anslinger, Katja
Bayer, Birgit
Siepermann, Kathrin
Niehues, Tim
Grimbacher, Bodo
Belohradsky, Bernd H.
Renner, Ellen D.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 130 (06) : 1426 - 1428
[39] Autosomal Dominant Hyper-IgE Syndrome Without Significantly Elevated IgE
Carsten S. Larsen
Mette Christiansen
Trine H. Mogensen
Journal of Clinical Immunology, 2019, 39 : 827 - 831
[40] Autosomal Dominant Hyper-IgE Syndrome Without Significantly Elevated IgE
Larsen, Carsten S.
Christiansen, Mette
Mogensen, Trine H.
JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 (08) : 827 - 831

← 1 2 3 4 5 →